Skip to main content

Regression in Adolescents and Adults with Down Syndrome

  • 816 Accesses

Abstract

There has been a growing number of clinical case reports of regression in adolescents and adults with Down syndrome who have shown unexpected and severe regression in cognitive and adaptive functioning, motor function, communication skills, and behavior. In this chapter, we call this adult regression syndrome. It most commonly affects people with Down syndrome in their teens and twenties and is associated with cognitive-executive impairment, social withdrawal, loss of functional language and previously acquired adaptive skills, lasting greater than 3 months. The differential diagnosis is extensive suggesting that the brains of individuals with Down syndrome are vulnerable to further impairment from a variety of underlying causes. Several of the most important diagnoses are discussed further. Prognosis is highly dependent on both the cause and the certainty of the diagnosis. Further study is needed to improve our understanding of adult regression syndrome.

Keywords

  • Adolescents with Down syndrome
  • Adults with Down syndrome
  • Adult regression syndrome
  • Auto-immunity
  • Catatonia
  • Down syndrome

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-3-319-90083-4_7
  • Chapter length: 20 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-3-319-90083-4
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   139.99
Price excludes VAT (USA)
Hardcover Book
USD   179.99
Price excludes VAT (USA)
Fig. 7.1

References

  1. Akahoshi K, Matsuda H, Funahashi M, Hanaoka T, Suzuki Y. Acute neuropsychiatric disorders in adolescents and young adults with Down syndrome: Japanese case reports. Neuropsychiatr Dis Treat. 2012;8:339–45. https://doi.org/10.2147/NDT.S32767.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  2. Anwar AJ, Walker JD, Frier BM. Type 1 diabetes mellitus and Down’s syndrome: prevalence, management, and diabetic complications. Diabet Med. 1998;15:160–3. https://doi.org/10.1002/(SICI)1096-9136(199802)15:2<160::AID-DIA537>3.0.CO;2-J.

    CAS  CrossRef  PubMed  Google Scholar 

  3. Armangue T, Petit-Pedrol M, Dalmau J. Autoimmune encephalitis in children. J Child Neurol. 2012;27:1460–90. https://doi.org/10.1177/0883073812448838.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  4. Bergholdt R, Eising S, Nerup J, Pociot F. Increased prevalence of Down’s syndrome in individuals with type 1 diabetes in Denmark: a nationwide population-based study. Diabetologia. 2006;49:1179–82. https://doi.org/10.1007/s00125-006-0231-6.

    CAS  CrossRef  Google Scholar 

  5. Bouziat R, Hinterleitner R, Brown JJ, Stencel-Baerenwald JE, Ikizler M, Mayassi T, Jabri B. Reovirus infection triggers inflammatory responses to dietary antigens and development of celiac disease. Science. 2017;356:44–50. https://doi.org/10.1126/science.aah5298.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  6. Capone GT, Grados MA, Kaufmann WE, Bernard-Ripoll S, Jewell A. Down syndrome and comorbid autism-spectrum disorder: characterization using the aberrant behavior checklist. Am J Med Genet. 2005;134:373–80. https://doi.org/10.1002/ajmg.a.30622.

    CrossRef  PubMed  Google Scholar 

  7. Capone GT, Goyal P, Ares W, Lannigan E. Neurobehavioral disorders in children, adolescents, and young adults with Down syndrome. Am J Med Genet C Semin Med Genet. 2006;142:158–72.

    CrossRef  Google Scholar 

  8. Capone G, Aidikoff J, Taylor K, Rykiel N. Adolescents and young adults with Down syndrome presenting to a medical clinic with depression: co-morbid obstructive sleep apnea. Am J Med Genet A. 2013;161:2188–96.

    CrossRef  Google Scholar 

  9. Castillo H, Patterson B, Hickey F, Kinsman A, Howard JM, Mitchell T, Molloy CA. Difference in age at regression in children with autism with and without Down syndrome. J Dev Behav Pediatr. 2008;29:89–93. https://doi.org/10.1097/DBP.0b013e318165c78d.

    CrossRef  PubMed  Google Scholar 

  10. Castro P, Zaman S, Holland A. Alzheimer’s disease in people with Down’s syndrome: the prospects for and the challenges of developing preventative treatments. J Neurol. 2017;264:804–13. https://doi.org/10.1007/s00415-016-8308-8.

    CrossRef  PubMed  Google Scholar 

  11. Daniels J. Catatonia: clinical aspects and neurobiological correlates. J Neuropsychiatry Clin Neurosci. 2009;21:371–80. https://doi.org/10.1176/appi.neuropsych.21.4.371.

    CAS  CrossRef  PubMed  Google Scholar 

  12. Devenny DA, Matthews A. Regression: atypical loss of attained functioning in children and adolescents with Down syndrome. In: Hodapp RM, editor. International review of research in developmental disabilities, vol. 41. Oxford: Academic Press; 2011. p. 233–64.

    CrossRef  Google Scholar 

  13. Down Syndrome Medical Interest Group-USA Work Group on Regression. July 2017. https://www.dsmig-usa.org.

  14. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin’s error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2010;36:314–20. https://doi.org/10.1093/schbul/sbp059.

    CrossRef  PubMed  Google Scholar 

  15. Francis A, Fink M, Appiani F, Bertelsen A, Bolwig TG, Braunig P, Caroff SN, Carroll BT, Cavanna AE, Cohen D, Cottencin O, Cuesta MJ, Daniels J, Dhossche D, Fricchione GL, Gazdag G, Ghaziuddin N, Healy D, Klein D, Kruger S, Lee JW, Mann SC, Mazurek M, McCall WV, McDaniel WW, Northoff G, Peralta V, Petrides G, Rosebush P, Rummans TA, Shorter E, Suzuki K, Thomas P, Vaiva G, Wachtel L. Catatonia in the diagnostic and statistical manual of mental disorders, fifth edition. J ECT. 2010;26:246–7. https://doi.org/10.1097/YCT.0b013e3181fe28bd.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  16. Ghaziuddin M, Tsai LY, Ghaziuddin N. Autism in Down’s syndrome: presentation and diagnosis. J Intellect Disabil Res. 1992;36:449–56.

    CrossRef  Google Scholar 

  17. Ghaziuddin N, Nassiri A, Miles JH. Catatonia in Down syndrome: a treatable cause of regression. Neuropsychiatr Dis Treat. 2015;11:941–9. https://doi.org/10.2147/NDT.S77307.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  18. Head E, Powell D, Gold BT, Schmitt FA. Alzheimer’s disease in Down syndrome. Eur J Neurogen Dis. 2012;1:353–64.

    Google Scholar 

  19. Hepburn S, Philofsky A, Fidler DJ, Rogers S. Autism symptoms in toddlers with Down syndrome: a descriptive study. J Appl Res Intellect Disabil. 2008;21:48–57. https://doi.org/10.1111/j.1468-3148.2007.00368.x.

    CrossRef  PubMed  Google Scholar 

  20. Hestnes A, Daniel SE, Lees AJ, Brun A. Down’s syndrome and Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1997;62:289.

    CAS  CrossRef  Google Scholar 

  21. Jacobs J, Schwartz A, McDougle CJ, Skotko BG. Rapid clinical deterioration in an individual with Down syndrome. Am J Med Genet A. 2016;170:1899–902. https://doi.org/10.1002/ajmg.a.37674.

    CrossRef  PubMed  Google Scholar 

  22. Kent L, Evans J, Paul M, Sharp M. Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol. 1999;41:153–8.

    CAS  CrossRef  Google Scholar 

  23. Kinik ST, Ozcay F, Varan B. Type I diabetes mellitus, Hashimoto’s thyroiditis and celiac disease in an adolescent with Down syndrome. Pediatr Int. 2006;48:433–5. https://doi.org/10.1111/j.1442-200X.2006.02238.x.

    CrossRef  PubMed  Google Scholar 

  24. Kirkhart R, Ahuja N, Lee JW, Ramirez J, Talbert R, Faiz K, Ungvari GS, Thomas C, Carroll BT. The detection and measurement of catatonia. Psychiatry (Edgmont). 2007;4:52–6.

    Google Scholar 

  25. Krinsky-McHale SJ, Jenkins EC, Zigman WB, Silverman W. Ophthalmic disorders in adults with Down syndrome. Curr Gerontol Geriatr Res. 2012;2012:974253. https://doi.org/10.1155/2012/974253.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  26. Kumar V, Rajadhyaksha M, Wortsman J. Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol. 2001;8:678–85. https://doi.org/10.1128/CDLI.8.4.678-685.2001.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  27. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol. 1989;46(8):849–53.

    CAS  CrossRef  Google Scholar 

  28. Leroy A, Naudet F, Vaiva G, Francis A, Thomas P, Amad A. Is electroconvulsive therapy an evidence-based treatment for catatonia? A systematic review and meta-analysis. Eur Arch Psychiatry Clin Neurosci. 2017; https://doi.org/10.1007/s00406-017-0819-5.

    CrossRef  Google Scholar 

  29. Mann DM. The pathological association between Down syndrome and Alzheimer disease. Mech Ageing Dev. 1988;43:99–136.

    CAS  CrossRef  Google Scholar 

  30. Mårild K, Stephansson O, Grahnquist L, Cnattingius S, Söderman G, Ludvigsson JF. Down syndrome is associated with elevated risk of celiac disease: a nationwide case-control study. J Pediatr. 2013;163:237–42. https://doi.org/10.1016/j.jpeds.2012.12.087.

    CrossRef  PubMed  Google Scholar 

  31. Miles J. Catatonia as a cause of regression in Down syndrome. Presentation at the annual symposium of the Down Syndrome Medical Interest Group-USA, Sacramento, CA. 2017.

    Google Scholar 

  32. Mircher C, Cieuta-Walti C, Marey I, Rebillat AS, Cretu L, Milenko E, Conte M, Sturtz F, Rethore MO, Ravel A. Acute regression in young people with Down syndrome. Brain Sci. 2017;7:E57. https://doi.org/10.3390/brainsci7060057.

    CrossRef  PubMed  Google Scholar 

  33. Moran JA, Rafii MS, Keller SM, Singh BK, Janicki MP, American Academy of Developmental Medicine and Dentistry, Rehabilitation Research and Training Center on Aging with Developmental Disabilities at University of Illinois at Chicago, American Association on Intellectual and Developmental Disabilities. The National Task Group on Intellectual Disabilities and Dementia Practices consensus recommendations for the evaluation and management of dementia in adults with intellectual disabilities. Mayo Clin Proc. 2013;88:831–40. https://doi.org/10.1016/j.mayocp.2013.04.024.

    CrossRef  PubMed  Google Scholar 

  34. Myers BA, Pueschel SM. Major depression in a small group of adults with Down syndrome. Res Dev Disabil. 1995;16:285–99.

    CAS  CrossRef  Google Scholar 

  35. Padhy SK, Parakh P, Sridhar M. The catatonia conundrum: controversies and contradictions. Asian J Psychiatr. 2014;7:6–9. https://doi.org/10.1016/j.ajp.2013.07.006.

    CrossRef  PubMed  Google Scholar 

  36. Pellegrini FP, Marinoni M, Frangione V, Tedeschi A, Gandini V, Ciglia F, Mortara L, Accolla RS, Nespoli L. Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol. 2012;169:238–43. https://doi.org/10.1111/j.1365-2249.2012.04610.x.

    CAS  CrossRef  PubMed  PubMed Central  Google Scholar 

  37. Popova G, Paterson WF, Brown A, Donaldson MD. Hashimoto’s thyroiditis in Down’s syndrome: clinical presentation and evolution. Horm Res. 2008;70:278–84. https://doi.org/10.1159/000157874.

    CAS  CrossRef  PubMed  Google Scholar 

  38. Prasher V. Disintegrative syndrome in young adults [Letter to the editor]. Irish J Psychol Med. 2002;19:101.

    CrossRef  Google Scholar 

  39. Prasher VP, Sachdeva N, Tarrant N. Diagnosing dementia in adults with Down’s syndrome. Neurodegen Dis Manag. 2015;5:249–56. https://doi.org/10.2217/nmt.15.8.

    CrossRef  Google Scholar 

  40. Principi N, Benoli MG, Bianchini S, Esposito S. J Clin Virol. 2017;96:26–31. https://doi.org/10.1016/j.jcv.2017.09.003.

    CrossRef  PubMed  Google Scholar 

  41. Rasmussen P, Borjesson O, Wentz E, Gillberg C. Autistic disorders in Down syndrome: background factors and clinical correlates. Dev Med Child Neurol. 2001;43:750–4.

    CAS  CrossRef  Google Scholar 

  42. Rollin H. Personality in mongolism with special reference to the incidence of catatonic psychosis. Am J Ment Defic. 1946;51:219–37.

    CAS  PubMed  Google Scholar 

  43. Sabbagh M, Edgin J. Clinical assessment of cognitive decline in adults with Down syndrome. Curr Alzheimer Res. 2016;13:30–4.

    CAS  CrossRef  Google Scholar 

  44. Shorter E. Making childhood catatonia visible, separate from competing diagnoses (Comment). Acta Psychiatr Scand. 2012;125:3–10. https://doi.org/10.1111/j.1600-0447.2011.01788.x.

    CrossRef  PubMed  PubMed Central  Google Scholar 

  45. Stein DS, Munir KM, Karweck AJ, Davidson EJ, Stein MT. Developmental regression, depression, and psychosocial stress in an adolescent with Down syndrome. J Dev Behav Pediatr. 2013;34:216–8. https://doi.org/10.1097/DBP.0b013e31828b2b42.

    CrossRef  PubMed  Google Scholar 

  46. Tyrrell J, Cosgrave M, McCarron M, McPherson J, Calvert J, Kelly A, McLaughlin M, Gill M, Lawlor BA. Dementia in people with Down’s syndrome. Int J Geriatr Psychiatry. 2001;16:1168–74.

    CAS  CrossRef  Google Scholar 

  47. Vieregge P, Ziemens G, Piosinski A, Freudenberg M, Kömpf D. Parkinsonian features in advanced Down’s syndrome. J Neural Transm Suppl. 1991;33:119–24.

    CAS  PubMed  Google Scholar 

  48. Warren AC, Holroyd S, Folstein FM. Major depression in Down’s syndrome. Br J Psychiatry. 1989;155:202–5.

    CAS  CrossRef  Google Scholar 

  49. Wisniewski KE, French JH, Rosen JF, Kozlowski PB, Tenner M, Wisniewski HM. Basal ganglia calcification (BGC) in Down’s syndrome (DS) – Another manifestation of premature aging. Ann N Y Acad Sci. 1982;396:179–89.

    CAS  CrossRef  Google Scholar 

  50. Worley G, Crissman BG, Cadogan E, Milleson C, Adkins DW, Kishnani PS. Down syndrome disintegrative disorder: new-onset autistic regression, dementia, and insomnia in older children and adolescents with Down syndrome. J Child Neurol. 2015;30:1147–52. https://doi.org/10.1177/0883073814554654.

    CrossRef  PubMed  Google Scholar 

  51. Zigman WB, Lott IT. Alzheimer’s disease in Down syndrome: neurobiology and risk. Ment Retard Dev Disabil Res Rev. 2007;13:237–46. https://doi.org/10.1002/mrdd.20163.

    CrossRef  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Brian Chicoine .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Verify currency and authenticity via CrossMark

Cite this chapter

Chicoine, B., Capone, G. (2019). Regression in Adolescents and Adults with Down Syndrome. In: Prasher, V., Janicki, M. (eds) Physical Health of Adults with Intellectual and Developmental Disabilities. Springer, Cham. https://doi.org/10.1007/978-3-319-90083-4_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-90083-4_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-90082-7

  • Online ISBN: 978-3-319-90083-4

  • eBook Packages: MedicineMedicine (R0)